T1	Participants 19 42	venous thromboembolism.
T2	Participants 44 102	Patients with pulmonary embolism or deep venous thrombosis
T3	Participants 203 245	patients with an enhanced risk of bleeding
T4	Participants 335 370	patients without these risk factors
T5	Participants 528 574	patients receiving continuous heparin therapy.
T6	Participants 1227 1269	patients without risk factors for bleeding
T7	Participants 1425 1462	patients with a high risk of bleeding
